Northwest Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Net Income	-62.6	-136.85	179.13	-538.37	-23.57	-35.79	-73.14	-80.21	-114.74	-135.63	Upgrade
Depreciation & Amortization	1.73	1.5	0.59	0.43	-0.3	1.29	0.44	0.19	0.06	0.01	Upgrade
Share-Based Compensation	4.41	12.3	15.5	52.21	1.82	14.29	0.84	0.13	40.77	21.33	Upgrade
Other Operating Activities	2.82	70.28	-233.51	453.64	-9.81	-14.37	35.37	24.25	-4.69	59.72	Upgrade
Operating Cash Flow	-53.64	-52.78	-38.3	-32.09	-31.86	-34.59	-36.5	-55.65	-78.61	-54.58	Upgrade
Capital Expenditures	-3.44	-2.9	-6.02	-6.61	-0.36	-0.19	-0.01	-4.94	-6.75	-33.73	Upgrade
Acquisitions	0	0	0	-1.53	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	45.6	0.22	-	-	-2.63	Upgrade
Investing Cash Flow	-3.44	-2.9	-6.02	-8.14	-0.36	45.4	0.21	-4.94	-6.75	-36.35	Upgrade
Common Stock Issued	15.05	9.47	4.07	26.81	6.87	1.16	11.63	26.4	81.66	58.44	Upgrade
Other Financing Activities	37.71	32.5	44.06	25.88	3.08	6.71	22.66	11.9	12.58	27.38	Upgrade
Financing Cash Flow	52.76	41.97	48.13	52.7	9.95	7.87	34.29	38.31	94.24	85.82	Upgrade
Net Cash Flow	-4.84	-8.2	5.19	9.61	-21.85	22.11	-6.75	-16.18	8.42	-5.11	Upgrade
Free Cash Flow	-57.07	-55.68	-44.31	-38.7	-32.22	-34.78	-36.5	-60.59	-85.36	-88.3	Upgrade
Free Cash Flow Margin	-2954.14%	-3308.20%	-4409.35%	-2997.91%	-1336.89%	-8441.50%	-10863.99%	-9725.68%	-4908.51%	-6073.11%	Upgrade
Free Cash Flow Per Share	-0.05	-0.05	-0.04	-0.05	-0.06	-0.08	-0.15	-0.55	-1.10	-1.49	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.